2023
DOI: 10.1016/j.ajps.2023.100854
|View full text |Cite
|
Sign up to set email alerts
|

CRISPR/Cas9 systems: Delivery technologies and biomedical applications

Yimin Du,
Yanfei Liu,
Jiaxin Hu
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 225 publications
(267 reference statements)
0
8
0
Order By: Relevance
“…Off-target effects are a limitation of CRISPR/Cas9 technology and are considered a significant risk in in vivo gene therapy ( Du et al, 2023 ). These effects occur when Cas9 proteins bind to PAM-like sequences or when guide RNAs (gRNAs) bind to unexpected nucleotide sequences at the target site.…”
Section: Limitations Of Crispr/cas9 In Disease Treatment and Applicationmentioning
confidence: 99%
See 2 more Smart Citations
“…Off-target effects are a limitation of CRISPR/Cas9 technology and are considered a significant risk in in vivo gene therapy ( Du et al, 2023 ). These effects occur when Cas9 proteins bind to PAM-like sequences or when guide RNAs (gRNAs) bind to unexpected nucleotide sequences at the target site.…”
Section: Limitations Of Crispr/cas9 In Disease Treatment and Applicationmentioning
confidence: 99%
“…The immune system’s reaction triggered by the Cas9 protein or vector in the host represents a significant challenge in the application of CRISPR/Cas9 technology ( Du et al, 2023 ). The Cas9 protein, originating from Streptococcus pyogenes, is considered an external antigen that can provoke an immune response upon introduction into the body ( Charlesworth et al, 2019 ).…”
Section: Limitations Of Crispr/cas9 In Disease Treatment and Applicationmentioning
confidence: 99%
See 1 more Smart Citation
“…CRISPR can be used to engineer immune cells to express chimeric antigen receptors (CARs) or enhance antipathogen effector functions, thereby increasing the efficacy of immunotherapeutic approaches against zoonotic diseases [108][109][110]. CRISPRmediated genome editing in animal models can facilitate the preclinical evaluation of immunotherapies, accelerate their application in clinical practice, and provide reliable efficacy information.…”
Section: The Use Of Crispr-cas9 In the Development Of Vaccines Tradit...mentioning
confidence: 99%
“…To identify the precise genetic mutations causing cancer and understand their mechanisms, CRISPR/Cas9 gene editing for tumor cells and immune cells holds great potential in addition to traditional therapeutic approaches like surgery, radiotherapy, chemotherapy, and immunotherapy. Because of the genetic precision that CRISPR/Cas9 provides, treating cancers effectively may now be approached from a different perspective 20,21…”
Section: Applications In Biotechnology Medicine and Environmental Sci...mentioning
confidence: 99%